Calimmune was founded in 2006 based on gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies).
Timeline
May 2015
Calimmune raises a $15,900,000 series B round from Alexandria Venture Investments, RA Capital Management and Translational Accelerator.
2006
Calimmune was founded by David Baltimore and Louis Breton.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring
Web
References
Organization
CompanyCompany attributes
Biotechnology
Stem cell
Gene therapy
Healthcare
Genetics
Therapeutics
Los Angeles
California
United States
King of Prussia, Pennsylvania
Tucson, ArizonaCompany Operating Status
Closed
B2X
B2BFounder
David BaltimoreLegal Name
Calimmune, Inc.
Legal classification
CorporationDate Incorporated
2006
Number of Employees (Ranges)
5 – 9
Full Address
5151 East Broadway Boulevard Suite 1020 Tucson, AZ 85711 United States
CIK Number
RA Capital Management
Alexandria Venture Investments
Mark SolonFounded Date
January 1, 2006
Total Funding Amount (USD)
15,900,000
Latest Funding Round Date
May 2015
Latest Funding Type
Series B roundPatents Assigned (Count)
1
Categories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Blessing Nwodo
Experienced writer - 3
Dushyant Soni
Researcher - 4
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 5
Amy Sar
Data acquisition Golden, computational linguist - 6
Henry Ogolla
Passionate about reading and writing. - 7
Duzenko Andrey
Extensive experience in development and interaction with the community - 8
Katrina-Kay Pettitt
Data Duchess @ Golden - 9
Wyckliffe Otieno
Dedicated information technology enthusiast. - 10
Dhruv Sharma
Researcher
